GUEST: Eli Casdin, Managing Partner of Casdin Capital, on the biotech sector, drug pricing and impact of policy to the FDA approval process.
What's Trending in the Molecular World
It’s a realistic blueprint for how tech could change medicine. But it’s also an emblem of how long that transformation will take. Read more here.
The controversial laboratory tool known as CRISPR may have found a whole new world to conquer. Read more here.
Software Engineering Manager Kevin Hobson had only recently started his new job at the New York medical software company Flatiron Health when, in January 2016, his bosses flew him down to Florida. Read more here.
Scientists have solved fundamental problems that were holding back cures for rare hereditary disorders
When Kala Looks gave birth to fraternal twin boys in January 2015, she and her husband, Philip, had no idea that one of them was harboring a deadly mutation in his genes. Read more here.
The quest for artificial meat inches forward—the company Memphis Meats announced today it has developed chicken and duck meat from cultured cells of each bird, producing “clean poultry.” Read more here.